Search
01/01/2026
Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT
Nagler, A, Galimard, JE, Kayser, S, Kulagin, A, Blaise, D, Parovichnikova, E, Versluis, J, Itäla-Remes, M, Choi, G, Bufarull, RM, Sica, S, Roeven, MWH, von dem Borne, P, Bazarbachi, A, Sanz, J, Mohty, M, Ciceri, F. Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT. BONE MARROW TRANSPLANTATION. 2026; 61(1)DOI:10.1038/s41409-025-02726-8. PMID:41109900. IF:5.200(Q1/1D).
07/02/2024
Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis (vol 20, pg 917, 2018)
Madaro, L, Passafaro, M, Sala, D, Etxaniz, U, Lugarini, F, Proietti, D, Alfonsi, MV, Nicoletti, C, Gatto, S, De Bardi, M, Rojas-Garcia, R, Giordani, L, Marinelli, S, Pagliarini, V, Sette, C, Sacco, A, Puri, PL. Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis (vol 20, pg 917, 2018). NATURE CELL BIOLOGY. 2024; 26(3)DOI:10.1038/s41556-024-01365-3. PMID:38326555. IF:19.100(Q1/1D).
09/07/2024
Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy
Fernández-Simón, E, Piñol-Jurado, P, Gokul-Nath, R, Unsworth, A, Alonso-Pérez, J, Schiava, M, Nascimento, A, Tasca, G, Queen, R, Cox, D, Suarez-Calvet, X, Díaz-Manera, J. Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophy. Frontiers in Cell and Developmental Biology. 2024; 12DOI:10.3389/fcell.2024.1399319. PMID:39045456. IF:4.300(Q1/1D).
01/04/2026
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients
Ganoza, CA, Westenberger, A, Paul, JJ, Curado, F, Rennecke, J, Mannepalli, S, Zonic, E, Saravanakumar, D, Paknia, O, Al-Ali, R, Laabs, B, Csoti, I, Valzania, F, Vandenberghe, W, Reetz, K, Afshari, M, Hassin-Baer, S, Fonoff, ET, Gruber, D, de Rosa, A, Musacchio, T, Aguiar, PD, Negrotti, A, Tumas, V, Gomez-Esteban, JC, Gurevich, T, Pavese, N, Kulisevsky, J, Sammler, E, Klein, C, Bauer, P, Beetz, C. Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients. MOVEMENT DISORDERS. 2026; 41(4)DOI:10.1002/mds.70161. PMID:41439479. IF:7.600(Q1/1D).
01/06/2026
Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation
Stocchi, F, Knecht, M, Marjanovic, I, Wach, A, Kopra, J, Kulisevsky, J. Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation. Neurology and Therapy. 2026; 15(3)DOI:10.1007/s40120-026-00898-z. PMID:41724884. IF:4.800(Q1/2D).
31/01/2026
Ten-year population-based assessment of multimorbidity burden progression in a regional cohort of 5.5 million adults
Valero-Bover, D, Monterde, D, Carot-Sans, G, Vela, E, González-Colom, R, Roca, J, Pontes, C, Michelena, X, Nogueras, MM, Aparicio, P, Corrales, I, Biec, T, Cano, I, Piera-Jiménez, J. Ten-year population-based assessment of multimorbidity burden progression in a regional cohort of 5.5 million adults. npj Digital Medicine. 2026; 9(1)DOI:10.1038/s41746-026-02395-x. PMID:41620560. IF:15.100(Q1/1D).